Target intelligence / Profile preview

X-linked inhibitor of apoptosis pseudogene 1 (XIAPP1)

Target
XIAPP1
Molecular classification
Other (Pseudogene)
01

Overview

X-linked inhibitor of apoptosis pseudogene 1 (XIAPP1), sometimes also referred to as Xiap-ps1, is a pseudogene closely related to the functional XIAP (BIRC4) gene. XIAPP1 arose through retrotransposition of spliced XIAP mRNA, resulting in a DNA sequence that is highly similar (92% identity) to XIAP but commonly lacks introns and contains premature stop codons preventing full-length protein production. No protein product has been observed and no tissue expression is confirmed in mouse models. Pseudogenes, in general, can modulate their parental gene expression through competitive interactions with miRNAs in cancer and other diseases, but there is no direct evidence that XIAPP1 acts as a miRNA decoy or has any specific biological or pathological function in humans. XIAPP1 is not considered a therapeutic target, receptor, or enzyme, and does not have any approved drugs targeting it or known biomarker utility. The name is scientifically accurate as a pseudogene, but as a therapeutic target this entry is incorrect and should not be included where protein- or receptor-level targets are required.

Other names
Xiap-ps1XIAP pseudogene 1
02

Biological functions

Post-transcriptional gene regulation via miRNA decoy (theoretical)None (no confirmed protein function)
03

Disease associations

Other (pseudogenes may play regulatory roles in cancer; no direct evidence for XIAPP1)

Beyond the preview

Go deeper on X-linked inhibitor of apoptosis pseudogene 1 (XIAPP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on X-linked inhibitor of apoptosis pseudogene 1 (XIAPP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call